NewEdge Advisors’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57 | Hold |
31
| – | – | ﹤0.01% | 3925 |
|
|
2025
Q1 | $63 | Hold |
31
| – | – | ﹤0.01% | 3844 |
|
|
2024
Q4 | $187 | Hold |
31
| – | – | ﹤0.01% | 3746 |
|
|
2024
Q3 | $305 | Hold |
31
| – | – | ﹤0.01% | 3654 |
|
|
2024
Q2 | $640 | Hold |
31
| – | – | ﹤0.01% | 3538 |
|
|
2024
Q1 | $1.41K | Hold |
31
| – | – | ﹤0.01% | 3439 |
|
|
2023
Q4 | $1.48K | Hold |
31
| – | – | ﹤0.01% | 3402 |
|
|
2023
Q3 | $1.27K | Sell |
31
-94
| -75% | -$3.84K | ﹤0.01% | 3137 |
|
|
2023
Q2 | $13.3K | Buy |
125
+62
| +98% | +$6.61K | ﹤0.01% | 2514 |
|
|
2023
Q1 | $18.7K | Buy |
63
+13
| +26% | +$3.85K | ﹤0.01% | 2363 |
|
|
2022
Q4 | $17 | Buy |
+50
| New | +$17 | ﹤0.01% | 3622 |
|